Northwest Biotherapeutics Stock Forecast

Buy candidate since Jan 17, 2025 Gain 0.36%

The Northwest Biotherapeutics stock price gained 0.357% on the last trading day (Tuesday, 21st Jan 2025), rising from $0.280 to $0.281. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 5.77% from a day low at $0.272 to a day high of $0.288. The price has been going up and down for this period, and there has been a 0.39% gain for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 289 thousand more shares were traded than the day before. In total, 2 million shares were bought and sold for approximately $501.82 thousand.

The stock lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -3.23% during the next 3 months and, with a 90% probability hold a price between $0.245 and $0.296 at the end of this 3-month period.

Investment opportunities can be found at any hour. So, react immediately to market-moving news and capture more market opportunities when convenient for you. You can trade over 10,000 US Stocks and ETFs, US Equity Index options, US Treasuries – and more - around the clock. Interactive Brokers’ dual market centers ensure reliable and dependable overnight trading on your timetable. (Member SIPC)

NWBO Signals & Forecast

Mostly positive signals in the chart today. The Northwest Biotherapeutics stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $0.269 and $0.274. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Thursday, December 19, 2024, and so far it has risen 9.64%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Northwest Biotherapeutics has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk.

Support, Risk & Stop-loss for Northwest Biotherapeutics stock

Northwest Biotherapeutics finds support from accumulated volume at $0.272 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.0157 between high and low, or 5.77%. For the last week, the stock has had daily average volatility of 4.76%.

Our recommended stop-loss: $0.265 (-5.71%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 19 days ago.)

Trading Expectations (NWBO) For The Upcoming Trading Day Of Wednesday 22nd

For the upcoming trading day on Wednesday, 22nd we expect Northwest Biotherapeutics to open at $0.280, and during the day (based on 14 day Average True Range), to move between $0.265 and $0.297, which gives a possible trading interval of +/-$0.0162 (+/-5.77%) up or down from last closing price. If Northwest Biotherapeutics takes out the full calculated possible swing range there will be an estimated 11.55% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.272 (3.20%) than the resistance at $0.290 (3.24%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Northwest Biotherapeutics stock A Buy?

Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term.

Current score: 1.523 Buy Candidate Unchanged

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

Predicted Fair Opening Price

Predicted fair opening price on January 22, 2025 - $0.280 ( 0.202%).